NINO MIMINOSHVILI: Open Payments
NPI 1568213510 · WARREN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $196 |
| Astellas Pharma US Inc | 4 | $122 |
| ABBVIE INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Amgen Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Auvelity, Veozah, FARXIGA, MAVYRET, CREON, REPATHA, ACCRUFER, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
